Recombinant plasmid stably expressing CD163 receptor protein, recombinant lentivirus and porcine alveolar macrophage cell line and construction method thereof
A technology of alveolar macrophages and recombinant lentivirus, applied in the direction of receptors/cell surface antigens/cell surface determinants, viruses/bacteriophages, chemical instruments and methods, etc., can solve the problem of pathogenic microorganisms invading the body, difficult to obtain pPAM, Virus persistent infection and other problems, to achieve the effect of improving industrial production efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0052] This embodiment provides a recombinant plasmid (named pLV-EGFP-CD163) for the expression of CD163 receptor, and its construction method is as follows:
[0053] 1. Cloning and sequencing of CD163 gene:
[0054] Obtain pPAM cells from the PRRSV negative piglet lung of 4-6 weeks of age, design primer (primer sequence as shown in table 1) according to the gene sequence of pig CD163, utilize PCR method to amplify pig CD163 gene (the reaction system of PCR amplification and The reaction conditions are shown in Table 2 and Table 3).
[0055] Table 1 is used to amplify the primer of CD163 gene
[0056]
[0057] Table 2 PCR reaction system
[0058]
[0059]
[0060] Table 3 PCR reaction conditions
[0061]
[0062] 2. Construct the cloning plasmid pEASY-T1-CD163:
[0063] The porcine CD163 gene was ligated with the cloning vector pEASY-T1 (the ligation system is shown in Table 4), and the obtained cloning plasmid was sequenced, and the sequencing results were com...
Embodiment 2
[0078] This example provides a recombinant lentivirus and porcine alveolar macrophage cell line stably expressing CD163 receptor expression, the construction method of which is as follows:
[0079] 1. Preparation of recombinant lentivirus:
[0080] Lenti-X 293T cells were cultured in DMEM containing 10% FBS at 37°C and 5% CO2. 24 hours before transfection, logarithmic phase 293T cells were digested with trypsin, inoculated in 100 mm tissue culture dishes (medium volume 8 mL), shaken gently, and incubated at 37° C. with 5% CO 2 . Transfection experiments were performed when the cell density reached 80%-90%.
[0081] Dilute lentiviral vector plasmid (pLV-EGFP-CD163) DNA with sterile water and mix well by vortexing. The resulting DNA solution was added to Lenti-X packaging single injection (VSV-G) tubes. Cap tightly and vortex the resulting solution for 20 s. After incubating at room temperature for 10 min, the DNA solution was slowly added dropwise to the 293T cell solution,...
experiment example
[0102] The identification and performance evaluation of the porcine alveolar macrophage cell line mPAM-CD163 stably expressing the CD163 receptor provided in Example 2 of the present invention are as follows:
[0103] 1. Western blot analysis:
[0104] Monolayers of cells washed with PBS were lysed with RIPA (Beyotime) lyase supplemented with protease inhibitors to prepare whole cell lysates. After boiling for 5 minutes, the samples were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and the protein bands were transferred to nitrocellulose filters. After blocking with 5% skim milk for 1 hour at room temperature, the membrane was incubated overnight at 4°C with the primary antibody rabbit anti-CD163 polyclonal antibody (1:1000 dilution). Then, the membrane was incubated with goat anti-rabbit secondary antibody (Earthox) (1:5000 dilution) for 1 hour at room temperature. Finally, a color solution is added to protect from light.
[0105] Test results su...
PUM
Property | Measurement | Unit |
---|---|---|
concentration | aaaaa | aaaaa |
molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com